RSS   Newsletter   Contact   Advertise with us
Post Online Media

iSTAR Medical strengthens board with two senior appointments

iSTAR MedicaliSTAR Medical SA, a private medical device company announced the appointments of Martin Wax and Marc Nolet de Brauwere to the board of directors.

Dr. Wax is currently the Chief Medical Officer and Executive Vice-President of R&D at PanOptica, Inc., a private biotechnology company specializing in ophthalmic pharmaceuticals. He was Vice President of R&D and Head of Ophthalmology Discovery Research and Preclinical Sciences at Alcon Laboratories from 2003-2008.

Article continues below

READ MORE Medical Facilities appoints Britt T. Reynolds as CEO

Dr. Wax was responsible for the creation and development of the Alcon pharmaceutical portfolio of compounds for the therapeutic areas of glaucoma, retina, allergy, dry eye and anti-infectives.

He is also Clinical Professor of Ophthalmology and Visual Sciences at Rutgers Medical School in Newark, N.J. and has been selected as one of the “Best Doctors in America” 2005-2008 by his peers.

He currently serves as the Chairman of the Board of Directors for Mimetogen, a biotechnology company based in Montreal, Canada. Dr. Wax has co-authored more than 200 publications and is a member of a number of renowned Ophthalmological Associations.

Mr. Nolet de Brauwere was appointed CEO of PhysIOL in 1997 when he took over the company. He previously held different positions at Petrofina S.A. in the US and as an associate at McKinsey.

He is currently an Independent Director at Bone Therapeutics, Cardiatis, Mymicroinvest, Endo Tools Therapeutics, Biotech Coaching and Aliaxis and is currently a Member of the Ashoka Support Network.

He holds a Master’s degree in Civil Mining Engineering from the Université Catholique de Louvain, Belgium and a Master’s degree in Industrial Management from the Katholieke Universiteit Leuven.




What to read next



 LATEST MOVES FROM Belgium 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy